Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.450
+0.020 (4.63%)
At close: Dec 20, 2024, 4:00 PM
0.468
+0.018 (4.11%)
After-hours: Dec 20, 2024, 6:08 PM EST
Sensei Biotherapeutics Employees
Sensei Biotherapeutics had 28 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
28
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,064,321
Market Cap
11.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 28 | 0 | - |
| Dec 31, 2022 | 28 | -28 | -50.00% |
| Dec 31, 2021 | 56 | 24 | 75.00% |
| Dec 31, 2020 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Lyra Therapeutics | 88 |
| Turnstone Biologics | 80 |
| BiomX | 71 |
| Jaguar Health | 49 |
| Sol-Gel Technologies | 36 |
| Imunon | 33 |
| Relmada Therapeutics | 20 |
| Talphera | 15 |
SNSE News
- 24 days ago - Sensei Biotherapeutics to Participate in Citi's 2024 Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 weeks ago - Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences - GlobeNewsWire
- 3 months ago - Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference - GlobeNewsWire
- 3 months ago - Sensei Biotherapeutics to Present at Upcoming Conferences - GlobeNewsWire
- 4 months ago - Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 months ago - Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 months ago - Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101 - GlobeNewsWire